Supreme Court: Rape Conviction Possible Without S.376 Charge if POCSO Case Fails on Age Proof || SC: Mere Long Possession Can't Establish Adverse Possession; Hostile Intent is Required || Supreme Court Finds Gaps in FSSAI’s Proposed Warning Labels for Foods High in Fat, Sugar and Salt || Supreme Court Quashes ITS Officer's 'Deadwood' Retirement, Orders Rs. 15 Lakh Payment || Uttarakhand HC: District Magistrate to Establish Public Helpline within 24 Hrs amid Water Pollution || Allahabad HC: Custodial Violence and Molestation Are Crimes, Not Police Duty || Gujarat High Court: Bombay Public Trust Registration is Covered by Section 43 of the Waqf Act || J&K&L HC: Advocates not Above Law, No Immunity from Lawful Police Inquiry || Gauhati HC: Talaq-e-Hasan Valid, Requires Registration under Assam Marriage Act || NCLAT: NCLT President Empowered to Transfer Cases from One Bench to Another

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :